Skip to main content
JBIO logo

JBIO · Jade Biosciences, Inc. · Debt

Track JBIO — free
$15.40 +0.07 (+0.42%) At close · Nov 17
Market Cap
$1.07B
Shares
69.19M
Volume · Nov 17 2.08M Avg daily vol (3M) 913.82K

Debt Profile

Completed filing coverage through Apr 29, 2022

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-09-30 USD 733,000 10-Q filed 2026-11-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Noncurrent operating lease liabilities
USD 594,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1798749 CUSIP 008064206 13F (30d) 165 filings 157 filers Visit website Investor relations